德视佳(01846)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01846 德视佳

已收盘 08-14 16:08:34

2.870

+0.220

+8.30%

最高2.890	最低2.870	成交量1.70万
今开2.890	昨收2.650	日振幅0.75%
总市值9.21亿	流通市值9.21亿	总股本3.21亿
成交额4.89万	换手率0.01%	流通股本3.21亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01846","market":"HK","secType":"STK","nameCN":"德视佳","latestPrice":2.87,"timestamp":1786694914659,"preClose":2.65,"halted":0,"volume":17000,"delay":0,"changeRate":0.08301886792452838,"floatShares":321000000,"shares":321000000,"eps":0.17026,"marketStatus":"已收盘","change":0.22,"latestTime":"08-14 16:08:34","open":2.89,"high":2.89,"low":2.87,"amount":48850,"amplitude":0.007547,"askPrice":2.87,"askSize":36000,"bidPrice":2.6,"bidSize":5000,"shortable":0,"etf":0,"ttmEps":0.17026,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"listingDate":1571068800000,"exchange":"SEHK","adjPreClose":2.65,"dividendRate":0.015366,"openAndCloseTimeList":[[1786671000000,1786680000000],[1786683600000,1786694400000]],"volumeRatio":2.073171,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01846","defaultTab":"news","newsList":[{"id":"1192067342","title":"德视佳（01846）拟于8月31日召开董事会审议2026年中期业绩及分红事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1192067342","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192067342?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:10","pubTimestamp":1786698642,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司（01846）8月14日公告称，公司董事会拟于2026年8月31日（星期一）召开会议，主要议程包括：  \n1. 审阅并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其刊发；  \n2. 考虑建议派付中期股息（如适用）；  \n3. 处理其他相关事宜。\n公司强调，公告内容的准确性与完整性由公司负责，香港交易及结算所有限公司及香港联合交易所有限公司对其概不负责。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191679753","title":"德视佳（01846）调整董事会及委员会架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1191679753","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191679753?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:57","pubTimestamp":1785751057,"startTime":"0","endTime":"0","summary":"2026年8月3日，德视佳国际眼科有限公司公告，自同日起，公司董事会及其下设三个专门委员会成员构成如下：。截至公告发布日，上述董事会及委员会调整已正式生效。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154592673","title":"德视佳(01846)任命Rens Laurentius Michaël Schoenmakers为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1154592673","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154592673?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:53","pubTimestamp":1785750789,"startTime":"0","endTime":"0","summary":"2026年8月3日，德视佳国际眼科有限公司公告称，自2026年8月3日起，Rens Laurentius Michal Schoenmakers先生正式出任公司执行董事，任期两年。董事会对其加入表示欢迎。Schoenmakers先生现年60岁，在欧洲、北美及亚洲的医疗器械、医疗科技及医疗保健行业累积超过20年的首席执行官及董事总经理经验。公司表示，Schoenmakers先生将持续负责欧洲市场业务发展，并在下一届股东周年大会上依公司章程轮值退任并可重选连任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656327958","title":"德视佳(01846)：Rens Laurentius Michaël Schoenmakers获委任为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2656327958","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656327958?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:47","pubTimestamp":1785750447,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德视佳(01846)发布公告，自2026年8月3日起，Rens Laurentius Michaël Schoenmakers先生，60岁，已获委任为执行董事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德视佳(01846)：Rens Laurentius Michaël Schoenmakers获委任为执行董事","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01846","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186222124","title":"德视佳国际眼科诊所：任命Rens Laurentius Michaël Schoenmakers为执行董事，自2026年8月3日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1186222124","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186222124?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:47","pubTimestamp":1785750429,"startTime":"0","endTime":"0","summary":"德视佳国际眼科诊所（EUROEYES）正式宣布，已任命Rens Laurentius Michaël Schoenmakers为执行董事。此项任命将于2026年8月3日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169965051","title":"德视佳更新2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1169965051","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169965051?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:41","pubTimestamp":1785746491,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司于2026年8月3日发布截至2026年7月31日止月份的证券变动月报表，显示公司在报告期内股本状况保持稳定。根据公告披露，德视佳国际眼科有限公司截至2026年7月31日的注册股本为10,000,000美元，折合1,000,000,000股普通股，每股面值0.01美元，与上月底相比无变化。公司月末已发行股份数量为320,706,000股，无库存股份，也未有股份增发、购回及注销活动。本月报表由公司秘书何家颖签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653979176","title":"德视佳(01846.HK)完成)完成收购荷兰眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2653979176","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653979176?lang=zh_cn&edition=full","pubTime":"2026-07-23 06:58","pubTimestamp":1784761109,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01846","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116686635","title":"德视佳（01846）7月22日完成1.31亿欧元荷兰眼科集团收购 并调拨2.17亿港元募资加码欧洲布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1116686635","media":"公告速递","labels":["corporation","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116686635?lang=zh_cn&edition=full","pubTime":"2026-07-23 06:50","pubTimestamp":1784760641,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司7月22日公告，公司已于当日收市后完成对目标公司EuroEyes Netherlands的收购及相关增资事项，交易被界定为「非常重大收购事项及关连交易」。上述代价由德视佳承担1.18625267亿欧元，Manco承担1.2725亿欧元，资金来源严格按照此前通函披露的顺序及优先次序支付。认购事项完成后，德视佳对EuroEyes Netherlands的总投资额为1.18625267亿欧元；参与者对认购股份的总出资为1.2725亿欧元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122758959","title":"德视佳特别股东大会全票通过四项普通决议","url":"https://stock-news.laohu8.com/highlight/detail?id=1122758959","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122758959?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:02","pubTimestamp":1784282531,"startTime":"0","endTime":"0","summary":"德视佳2026年7月17日公布，于当日举行的股东特别大会就四项普通决议进行表决，全部获高票通过。\\n\\n公告显示，出席会议并行使投票权的股份共计189,287,952股，占公司已发行股份总数320,706,000股的59.03%。\\n\\n— 第1项决议获189,287,952票赞成，赞成率100%，无反对票。\\n\\n公司称，由于上述各项决议的赞成票数均超过50%，全部以普通决议案获正式通过。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134319140","title":"德视佳更新6月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1134319140","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134319140?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:36","pubTimestamp":1782984972,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司于2026年7月2日发布2026年6月股份变动月报表，报告期截至2026年6月30日。根据公告披露，报告期内公司股本结构及股份数量未发生变化。根据公告，德视佳国际眼科有限公司的注册股本为1,000,000,000股，面值每股0.01美元，对应注册股本总额为10,000,000美元；截至2026年6月30日，公司普通股已发行股份和注册股本均保持稳定，分别为320,706,000股和10,000,000美元，未发生新增发行、购回或注销，也未出现库藏股变动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166236586","title":"德视佳(01846)7月17日召开股东特别大会　审议收购目标公司及向Manco增资约2,065万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166236586","media":"公告速递","labels":["merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166236586?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:56","pubTimestamp":1782824164,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司公告，将于2026年7月17日16:00在香港夏悫道18号海富中心1座24楼召开股东特别大会，拟表决四项普通决议：","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643750955","title":"德视佳(01846)：EuroEyes Netherlands拟向Manco发行认购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2643750955","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643750955?lang=zh_cn&edition=full","pubTime":"2026-06-16 21:15","pubTimestamp":1781615724,"startTime":"0","endTime":"0","summary":"根据认购协议，管理层已同意将彼自收购事项所获的部分所得款项再投资于EuroEyes Netherlands的股本内。待收购事项完成及认购事项完成后，EuroEyes Netherlands将继续为本公司的附属公司。在根据认购协议完成认购事项之日或前后，本公司、EuroEyes Netherlands、Manco及 STAK将就股本订立股东协议，并据此规范EuroEyes Netherlands的管理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01846","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151051661","title":"德视佳荷兰子公司与Fyeo Manco达成认购股份协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1151051661","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151051661?lang=zh_cn&edition=full","pubTime":"2026-06-16 21:02","pubTimestamp":1781614965,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司宣布，其荷兰子公司Euroeyes Netherlands已与Fyeo Manco达成协议，将向后者发行认购股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187960923","title":"德视佳拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1187960923","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187960923?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:43","pubTimestamp":1780562593,"startTime":"0","endTime":"0","summary":"德视佳公告显示，董事会已提请股东大会授予购回授权，最多可于授权期间内回购相当于已发行股份总数10%的股份。据公司资料，截至最后可行日期，德视佳已发行股份共计320,706,000股，意味着在条件获批且股本无变动的情况下，最高回购上限可达32,070,600股。过往12个月，德视佳股份价格在每股2.52港元至3.46港元区间波动。德视佳将于2026年6月30日召开股东大会审议该购回授权事宜。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德视佳拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105380565","title":"德视佳5月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1105380565","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105380565?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:32","pubTimestamp":1780306335,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司于2026年6月1日披露了截至2026年5月31日的证券变动月报。报告显示，公司法定/注册股本维持在总额USD 10,000,000不变，每股面值仍为USD 0.01，相应法定/注册股份数目为1,000,000,000股。根据月报，德视佳5月底的已发行普通股数量为320,706,000股，库藏股数量为0股，与上月底持平。公告显示，5月份未出现新发行股份、购回或注销股份等变动，公司股本处于稳定状态。本次公告由公司秘书何家穎签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164725298","title":"德视佳2026年4月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1164725298","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164725298?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:48","pubTimestamp":1777884503,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司于2026年5月4日披露了截至2026年4月30日的证券变动月度报告，显示公司股本在报告期内无任何新增发行、购回或注销活动，整体维持不变。报告显示，德视佳普通股在4月的经港交所上市发行股份总数为320,706,000股，相较上月底并无增减，库存股数量为0。公司确认，截至2026年4月30日，已遵循适用的香港联合交易所有限公司上市规则及相关法律法规，公司的公众持股比例持续符合上市要求。本次公告由公司秘书何家颖签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631638646","title":"德视佳(01846)第一季度眼科手术总数合计为7598例 同比增加约9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631638646","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631638646?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:37","pubTimestamp":1777545434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德视佳(01846)发布公告，根据本公司的初步统计数据及本公司目前可得的资料，本集团于2026年1月1日至2026年3月31日期间(2026年第一季度)进行的眼科手术总数合计为7598例，较2025年同期增加约9%(即于2025年1月1日至2025年3月31日：6997例眼科手术)。该增加主要得益于本集团瑞士业务的表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169354041","title":"德视佳（01846）2025年收入增长至7.96亿元 净利率降至7.1%并加强全球诊所布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1169354041","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169354041?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:04","pubTimestamp":1777453471,"startTime":"0","endTime":"0","summary":"德视佳于2025年收入7.96亿元港元，同比上升11.2%，主要受老花眼及屈光激光手术等眼科诊疗需求持续扩张所带动。然而，年内本公司拥有人应占溢利降至0.54亿元港元，较上年下滑33.8%，净利润率由11.8%显著回落至7.1%。公司称，销售费用及财务成本上升在一定程度上增加了盈利压力，每股基本盈利由24.93港仙减至17.03港仙。在财务方面，截至2025年末，德视佳总资产达到19.52亿元港元，资产增长率为22.1%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德视佳（01846）2025年收入增长至7.96亿元 净利率降至7.1%并加强全球诊所布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130600352","title":"德视佳更新3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1130600352","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130600352?lang=zh_cn&edition=full","pubTime":"2026-04-01 17:26","pubTimestamp":1775035585,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司于2026年4月1日发布2026年3月股份变动月报表，报告期截至2026年3月31日。德视佳国际眼科有限公司的法定/注册股本维持在1,000,000,000股普通股，每股面值USD0.01，对应注册股本为USD 10,000,000。截至2026年3月31日，公司股本总数保持不变，满足香港联交所关于公众持股量的要求。公司声明已遵守香港联交所《上市规则》及相关法律规定，公告由公司秘书何家穎签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623380075","title":"德视佳(01846.HK)2025年度溢利5663万港元 同比下降32.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623380075","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2623380075?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:57","pubTimestamp":1774969023,"startTime":"0","endTime":"0","summary":"格隆汇3月31日丨德视佳发布2025年度业绩。集团财政年度的总收益为7.96亿港元，同比上升11.2%，主要是由于用于治疗老花眼的晶体置换手术在所有地区均录得强劲增长。年内溢利5663万港元，同比下降32.9%。每股基本盈利每股基本盈利17.028港仙。　　截至2025年12月31日止12个月，集团总收益创下7.96亿港元的历史新高，较去年增加11.2%。该等分部的收益分别达448.8百万港元及33.2百万港元，同比增加分别为14.8%及26.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260331/32116801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.euroeyes.hk","stockEarnings":[{"period":"1week","weight":0.0392},{"period":"1month","weight":0.1134},{"period":"3month","weight":-0.035},{"period":"6month","weight":-0.1092},{"period":"1year","weight":-0.1698},{"period":"ytd","weight":-0.1237}],"compareEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":0.0434},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.0441},{"period":"1year","weight":-0.0085},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Euroeyes International Eye Clinic Ltd是一家总部位于德国的眼科视光学公司。该公司提供各种视力矫正服务，例如屈光激光手术、有晶状体眼手术、晶状体植入和晶状体置换手术。该公司的业务遍及德国、丹麦、英国和中国。","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":-0.055818},{"month":2,"riseRate":0.428571,"avgChangeRate":0.001865},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.089545},{"month":4,"riseRate":0.428571,"avgChangeRate":0.062935},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.016393},{"month":6,"riseRate":0.571429,"avgChangeRate":0.005388},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000504},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.007977},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.054822},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.022059},{"month":11,"riseRate":0.428571,"avgChangeRate":0.039908},{"month":12,"riseRate":0.428571,"avgChangeRate":0.041262}],"exchange":"SEHK","name":"德视佳","nameEN":"EUROEYES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德视佳(01846)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德视佳(01846)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德视佳,01846,德视佳股票,德视佳股票老虎,德视佳股票老虎国际,德视佳行情,德视佳股票行情,德视佳股价,德视佳股市,德视佳股票价格,德视佳股票交易,德视佳股票购买,德视佳股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德视佳(01846)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德视佳(01846)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}